Fluticasone Propionate

API Product
fluticasone-propionate
Product Status:
Commercial
Available Grades:
  • Inhalation
  • Micronized
  • Non-Micronized
Regulatory Status:
Korean DMF
CN DMF
JP DMF
US DMF
CEP
Production Sites:
  • Hovione Loures
Product Type:
  • Corticosteroids
CAS Number:
80474-14-2
Modes of Application:
  • Topical
  • Inhalation
  • Nasal
Common Indications:
  • Allergic rhinitis
  • Asthma
Last Inspection:
FDA May 2018

Hovione can customize Fluticasone propionate for inhalation with an unrivalled range of particle size reduction technologies for the production of tailor made API, featuring a near-perfect particle size distribution reproducibility with a low span and amorphous content, providing highly stable API.

Hovione Fluticasone Propionate is available since 2001 and is approved in branded, generic and 505b2 applications.

With a proven track record in developing and manufacturing high performance APIs Hovione offers a full range of API for inhalation, e.g. Salmeterol Xinafoate or Tiotropium Bromide.


This is not to be construed as a representation of non-infringement or as an offer to sell in those countries where such would constitute an infringement of third parties’ patent rights.

highlight

Contact Us

Please contact us if you have inquiries about our offering

http://go.hovione.com/l/47122/2014-08-06/9grc

Related files

Hovione Product Portfolio
pdf (706.84 KB)
Download